Liquid biopsy test for comprehensive tumor mutation
profiling across all solid cancers. Find out more.

Tissue-based test for comprehensive tumor mutation
profiling across all solid cancers. Find out more.

Residual disease detection and recurrence monitoring for patients with early-stage colorectal cancer. Find out more.

Monitor patient’s tumor response to immunotherapy or targeted therapy. Find out more.

Helping pharmaceutical companies accelerate precision oncology drug development. Find out more.